- call +1-201-465-4211
- email sales@mrinsights.biz
Oral solid dosage forms are the most commonly used pharmaceuticals to treat various disease conditions. Oral solid dosage forms are cost-effective and easy to manufacture in comparison with other dosage forms. They offer significant benefits to manufacturers such as trouble free packaging and transportation and increased chemical and physical stability. Oral solids offer many advantages to patients as well.
Scope of the Report:
This report focuses on the Oral Solid Dosage Pharmaceutical Formulation in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
North America dominated the global oral solid dosage pharmaceutical formulation market in revenue terms in 2017, and the trend is projected to continue throughout the forecast period.
The worldwide market for Oral Solid Dosage Pharmaceutical Formulation is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Gilead
Merck
Novartis
Pfizer
AbbVie
Boehringer Ingelheim
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Immediate Release
Extended Release
Others
Market Segment by Applications, can be divided into
Hospital Pharmacy
Retail Pharmacy
Drug Stores
Others
There are 15 Chapters to deeply display the global Oral Solid Dosage Pharmaceutical Formulation market.
Chapter 1, to describe Oral Solid Dosage Pharmaceutical Formulation Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Oral Solid Dosage Pharmaceutical Formulation, with sales, revenue, and price of Oral Solid Dosage Pharmaceutical Formulation, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Oral Solid Dosage Pharmaceutical Formulation, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Oral Solid Dosage Pharmaceutical Formulation market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Oral Solid Dosage Pharmaceutical Formulation sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Oral Solid Dosage Pharmaceutical Formulation Introduction
1.2 Market Analysis by Type
1.2.1 Immediate Release
1.2.2 Extended Release
1.2.3 Others
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacy
1.3.2 Retail Pharmacy
1.3.3 Drug Stores
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bristol-Myers Squibb
2.2.1 Business Overview
2.2.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Eli Lilly
2.3.1 Business Overview
2.3.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Gilead
2.4.1 Business Overview
2.4.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Gilead Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Merck
2.5.1 Business Overview
2.5.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Novartis
2.6.1 Business Overview
2.6.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 AbbVie
2.8.1 Business Overview
2.8.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 AbbVie Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Boehringer Ingelheim
2.9.1 Business Overview
2.9.2 Oral Solid Dosage Pharmaceutical Formulation Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Oral Solid Dosage Pharmaceutical Formulation Manufacturer Market Share in 2017
3.3.2 Top 6 Oral Solid Dosage Pharmaceutical Formulation Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Oral Solid Dosage Pharmaceutical Formulation Market Analysis by Regions
4.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Market Share by Regions
4.1.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Regions (2013-2018)
4.1.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Regions (2013-2018)
4.2 North America Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2013-2018)
4.3 Europe Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2013-2018)
4.5 South America Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2013-2018)
5 North America Oral Solid Dosage Pharmaceutical Formulation by Countries
5.1 North America Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Market Share by Countries
5.1.1 North America Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Countries (2013-2018)
5.1.2 North America Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Countries (2013-2018)
5.2 United States Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2013-2018)
5.3 Canada Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2013-2018)
5.4 Mexico Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2013-2018)
6 Europe Oral Solid Dosage Pharmaceutical Formulation by Countries
6.1 Europe Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Market Share by Countries
6.1.1 Europe Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Countries (2013-2018)
6.2 Germany Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2013-2018)
6.3 UK Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2013-2018)
6.4 France Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2013-2018)
6.5 Russia Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2013-2018)
6.6 Italy Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2013-2018)
7 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation by Countries
7.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Countries (2013-2018)
7.2 China Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2013-2018)
7.3 Japan Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2013-2018)
7.4 Korea Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2013-2018)
7.5 India Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2013-2018)
8 South America Oral Solid Dosage Pharmaceutical Formulation by Countries
8.1 South America Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Market Share by Countries
8.1.1 South America Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Countries (2013-2018)
8.1.2 South America Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2013-2018)
8.3 Argentina Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2013-2018)
8.4 Colombia Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2013-2018)
9 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation by Countries
9.1 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2013-2018)
9.3 UAE Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2013-2018)
9.4 Egypt Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2013-2018)
9.5 Nigeria Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2013-2018)
9.6 South Africa Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2013-2018)
10 Global Oral Solid Dosage Pharmaceutical Formulation Market Segment by Type
10.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Type (2013-2018)
10.1.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Type (2013-2018)
10.2 Immediate Release Sales Growth and Price
10.2.1 Global Immediate Release Sales Growth (2013-2018)
10.2.2 Global Immediate Release Price (2013-2018)
10.3 Extended Release Sales Growth and Price
10.3.1 Global Extended Release Sales Growth (2013-2018)
10.3.2 Global Extended Release Price (2013-2018)
10.4 Others Sales Growth and Price
10.4.1 Global Others Sales Growth (2013-2018)
10.4.2 Global Others Price (2013-2018)
11 Global Oral Solid Dosage Pharmaceutical Formulation Market Segment by Application
11.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Application (2013-2018)
11.2 Hospital Pharmacy Sales Growth (2013-2018)
11.3 Retail Pharmacy Sales Growth (2013-2018)
11.4 Drug Stores Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)
12 Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2018-2023)
12.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Growth Rate (2018-2023)
12.2 Oral Solid Dosage Pharmaceutical Formulation Market Forecast by Regions (2018-2023)
12.2.1 North America Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2018-2023)
12.2.2 Europe Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2018-2023)
12.2.3 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2018-2023)
12.2.4 South America Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2018-2023)
12.2.5 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2018-2023)
12.3 Oral Solid Dosage Pharmaceutical Formulation Market Forecast by Type (2018-2023)
12.3.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Type (2018-2023)
12.3.2 Global Oral Solid Dosage Pharmaceutical Formulation Market Share Forecast by Type (2018-2023)
12.4 Oral Solid Dosage Pharmaceutical Formulation Market Forecast by Application (2018-2023)
12.4.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Application (2018-2023)
12.4.2 Global Oral Solid Dosage Pharmaceutical Formulation Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Oral Solid Dosage Pharmaceutical Formulation Picture
Table Product Specifications of Oral Solid Dosage Pharmaceutical Formulation
Figure Global Sales Market Share of
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
